Mathieu Ferrari

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Blood cancer journal

Nature communications

Nature medicine

Journal of virology

Autolus

Queen Mary University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Autolus Jan 11 2016

United Kingdom

Associate director

Queen Mary University of London Apr 01 2014 - Jan 10 2016

United Kingdom

Post doctoral research fellow :: Experimental Medicine and Rheumatology

Education History

Queen Mary University of London Jan 05 2010 - Mar 31 2014

United Kingdom

PHD :: Experimental Medicine and Rheumatology

Universita degli Studi di Roma La Sapienza

Italy

MSC :: Istituto Superiore di Sanitá

Universita degli Studi di Roma Tor Vergata

Italy

BSC :: Microbiology

Publications

Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Shaun Cordoba, Shimobi Onuoha, Simon Thomas, Daniela Soriano Pignataro, Rachael Hough, Sara Ghorashian, Ajay Vora, Denise Bonney, Paul Veys, Kanchan Rao, Giovanna Lucchini, Robert Chiesa, Jan Chu, Liz Clark, Mei Mei Fung, Koval Smith, Carlotta Peticone, Muhammad Al-Hajj, Vania Baldan, Mathieu Ferrari, Saket Srivastava, Ram Jha, Frederick Arce Vargas, Kevin Duffy, William Day, Paul Virgo, Lucy Wheeler, Jeremy Hancock, Farzin Farzaneh, Sabine Domning, Yiyun Zhang, Nushmia Z Khokhar, Vijay G R Peddareddigari, Robert Wynn, Martin A Pule, Persis Jal Amrolia
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. Nature medicine 27 (10) (2021)
Mathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, Zulaikha Akbar, Reyisa Bughda, Katarina Lamb, Katarzyna Ward, Farhaan Parekh, Rajeev Karattil, Christopher Allen, Philip Wu, Vania Baldan, Giada Mattiuzzo, Emma M Bentley, Yasuhiro Takeuchi, James Sillibourne, Preeta Datta, Alexander Kinna, Martin Pule, Shimobi C Onuoha
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants. Journal of virology 95 (19) (2021)
Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha, Gary Wright, Jack Bartram, Rachel Richardson, Sarah J Albon, Joan Casanovas-Company, Fernanda Castro, Bilyana Popova, Krystle Villanueva, Jenny Yeung, Winston Vetharoy, Aleks Guvenel, Patrycja A Wawrzyniecka, Leila Mekkaoui, Gordon Weng-Kit Cheung, Danielle Pinner, Jan Chu, Giovanna Lucchini, Juliana Silva, Oana Ciocarlie, Arina Lazareva, Sarah Inglott, Kimberly C Gilmour, Gulrukh Ahsan, Mathieu Ferrari, Somayya Manzoor, Kim Champion, Tony Brooks, Andre Lopes, Allan Hackshaw, Farzin Farzaneh, Robert Chiesa, Kanchan Rao, Denise Bonney, Sujith Samarasinghe, Nicholas Goulden, Ajay Vora, Paul Veys, Rachael Hough, Robert Wynn, Martin A Pule, Persis Jal Amrolia
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nature medicine 25 (9) (2019)

Mathieu Ferrari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mathieu Ferrari